Product Images Sotalol Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Sotalol Hydrochloride NDC 59651-775 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - sotalol fig1

Figure 1 - sotalol fig1

Figure 1: Study 1 - sotalol fig2

Figure 1: Study 1 - sotalol fig2

Figure 2: Study 2 - sotalol fig3

Figure 2: Study 2 - sotalol fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 80 mg (100 Tablets Bottle) - sotalol fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 80 mg (100 Tablets Bottle) - sotalol fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 120 mg (100 Tablets Bottle) - sotalol fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 120 mg (100 Tablets Bottle) - sotalol fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 160 mg (100 Tablets Bottle) - sotalol fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 160 mg (100 Tablets Bottle) - sotalol fig6

This is a description for Sotalol HCI tablets, USP (AF). Each tablet contains 160 mg of Sotalol hydrochloride. This medication is distributed by Aurobindo Pharma USA, Inc. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure. The medication should be stored at 20° to 25°C (68° to 77°F). Please refer to the accompanying prescribing information for the usual dosage. The packaging includes GTIN, Serial Number, Expiry Date, LOT, and Coding Area.*

Chemical Structure - sotalol str

Chemical Structure - sotalol str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.